112 related articles for article (PubMed ID: 7232904)
21. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
[TBL] [Abstract][Full Text] [Related]
22. [Nicergoline in otorhinolaryngology].
Pech A; Gitenet P
Ann Otolaryngol Chir Cervicofac; 1975; 92(10-11):625-8. PubMed ID: 1211743
[No Abstract] [Full Text] [Related]
23. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
Battaglia A; Bruni G; Ardia A; Sacchetti G
J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
[TBL] [Abstract][Full Text] [Related]
24. [The effect of sermion on the main hemodynamic indices in patients with the initial manifestations of cerebral atherosclerosis].
Tokar' AV; Akhaladze NG; Ena LM; Rudaia ES; Severova NL
Vrach Delo; 1990 Feb; (2):27-30. PubMed ID: 2339544
[TBL] [Abstract][Full Text] [Related]
25. [Action of Nicergoline (Sermion) in chronic vascular disease in old age].
Michelangeli J; Sevilla M; Lavagna J; Darcourt G
Ann Med Psychol (Paris); 1975 Apr; 1(4):499-510. PubMed ID: 788599
[No Abstract] [Full Text] [Related]
26. Clinical study on nicergoline in peripheral arteriopathies.
Schönenberger F
Farmaco Prat; 1976 Nov; 31(11):561-7. PubMed ID: 797575
[No Abstract] [Full Text] [Related]
27. [Use of nicergoline (Sermion) in the treatment of migraine].
Prusiński A; Durko A; Selmaj K
Wiad Lek; 1984 Mar; 37(6):420-2. PubMed ID: 6385484
[No Abstract] [Full Text] [Related]
28. [Electroencephalographic study during long-term use of nicergoline].
Miletto D; Julou M
Ann Med Psychol (Paris); 1976 Dec; 134(5):824-31. PubMed ID: 1026140
[No Abstract] [Full Text] [Related]
29. Simultaneous study of haemodynamic, metabolic and behavioural sequelae in a model of cerebral ischaemia in aged rats: effects of nicergoline.
Le Poncin-Lafitte M; Grosdemouge C; Duterte D; Rapin JR
Gerontology; 1984; 30(2):109-19. PubMed ID: 6706123
[TBL] [Abstract][Full Text] [Related]
30. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
Cascone A; Liverta C; Pollini C
Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
[No Abstract] [Full Text] [Related]
31. The effects of nicergoline on spontaneously hypertensive rats and their offspring.
Moore N; Chadelaud M; Gügi B; Saligaut C; Berland C; Chrétien P; Daoust M; Boismare F
Clin Exp Hypertens A; 1983; 5(4):613-24. PubMed ID: 6851201
[TBL] [Abstract][Full Text] [Related]
32. [Effect of nicergoline on the intellectual performance (author's transl)].
Donoso A; Santander M; Sarce H
Rev Med Chil; 1979 Sep; 107(9):817-9. PubMed ID: 396627
[No Abstract] [Full Text] [Related]
33. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
Karyofilis A
Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
[No Abstract] [Full Text] [Related]
34. [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)].
Borgioli M; Merendino E; Ricci B
Arzneimittelforschung; 1979; 29(8a):1311-6. PubMed ID: 540076
[TBL] [Abstract][Full Text] [Related]
35. [Favorable effect of nicergoline on pruritus in chronic hemodialysis patients. Role of a hyper-alpha-adrenergic system?].
Rivory JP; Maheut H
Presse Med; 1984 Dec; 13(44):2703. PubMed ID: 6096843
[No Abstract] [Full Text] [Related]
36. [Value of nicergoline in the prevention of postoperative thrombophlebitis].
Kauffmann JP; Keller D; Calderoli H; Ackermann E; Hollender LF
Med Chir Dig; 1981; 10(2):169-72. PubMed ID: 7230952
[No Abstract] [Full Text] [Related]
37. [The hemodynamic effects of oral prazosine and intravenous nicergoline in heart failure (author's transl)].
Pornin M; Roland E; Lardoux H; Sellier P; Ourbak P; Maurice P
Ann Cardiol Angeiol (Paris); 1980; 29(5):379-84. PubMed ID: 7425504
[No Abstract] [Full Text] [Related]
38. [Nicergoline and severe isolated cranial injuries].
Alibert F; Devaux C; Sauger F; Winckler C
Agressologie; 1982; 23(E):93-8. PubMed ID: 7137483
[No Abstract] [Full Text] [Related]
39. Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs.
Calvagno M
Farmaco Prat; 1982 Jun; 37(6):200-5. PubMed ID: 7106277
[No Abstract] [Full Text] [Related]
40. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
Colombeau P; Ballanger P
J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
